Bibliography
- Gentile NM, Khanna S, Loftus EV Jr, et al. The epidemiology of microscopic colitis in olmsted county from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol 2014;12(5):838-42
- Wickbom A, Bohr J, Eriksson S, et al. Stable incidence of collagenous colitis and lymphocytic colitis in Orebro, Sweden, 1999-2008: a continuous epidemiologic study. Inflamm Bowel Dis 2013;19(11):2387-93
- Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996;39(6):846-51
- Ianiro G, Cammarota G, Valerio L, et al. Microscopic colitis. World J Gastroenterol 2012;18(43):6206-15
- Baert F, Schmit A, D’haens G, et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002;122(1):20-5
- Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 2003;52(2):248-51
- Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 2009;58(1):68-72
- Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 2002;123(4):978-84
- Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 2008;135(5):1510-16
- Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology 2014;146(5):1222-30. e1222
- Budesonide capsules vs. mesalazine granules vs. placebo in collagenous colitis. 2012. Available from: http://clinicaltrials.gov/show/NCT00450086
- Munch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis 2012;6(9):932-45
- Miehlke S, Hansen JB, Madisch A, et al. Risk factors for symptom relapse in collagenous colitis after withdrawal of short-term budesonide therapy. Inflamm Bowel Dis 2013;19(13):2763-7
- Chande N, Macdonald JK, Mcdonald JW. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009;104(1):235-41. quiz 234, 242